Reduction in expenditures on analgesics during one year of treatment of chronic tension headache with BoNT-A

Journal of Headache and Pain

Volumn 4, Issue 2, 2003, Pages 88-91

  Coloprisco, Gabriella ^a   De Filippis, Sergio ^a   Santi, Pier Giorgio ^a   Fiore, Giuseppe ^a   Rodio, Anna ^a   Martelletti, Paolo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; BOTULINUM TOXIN A; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONSULTATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; COST OF ILLNESS; DATA ANALYSIS; DOSE RESPONSE; DRUG COST; DRUG EFFICACY; ECONOMIC EVALUATION; FEMALE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; PAIN ASSESSMENT; PATIENT INFORMATION; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SELF MEDICATION; TENSION HEADACHE;

EID: 0041854346     PISSN: 11292369     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10194-003-0037-6     Document Type: Article

References (10)

1. Rollnik JD, Tanneberger O, Schubert M, Schneider U, Dengler R (2000) Treatment of tension-type headache with botulinum toxin type A: a double-blind, placebo-controlled study. Headache 40:300-305
2. Rasmussen BK, Jensen R, Olesen J (1992) Impact of headache on sickness absence and utilisation of medical services: a Danish population study. J Epidemiol Community Health 46(4):443-446
3. Martelletti P (2002) The unfinished war. J Headache Pain 3:115-116 (editorial)
4. Martelletti P, Leonardi M (2003) The global impact of migraine. J Headache Pain 4[Suppl 1]:S1-S2 (editorial)
5. Iannazzo S, Cattaruzza MS, De Filippis S et al (2003) Analgesic therapy for headache: consumption, appropriateness and costs. J Headache Pain 4[Suppl 1]:S85-S88
6. Smuts JA, Baker MK, Smuts HM, Stassen JMR, Rossouw E, Barnard PWA (1999) Prophylactic treatment of chronic tension-type headache using botulinim toxin type A. Eur J Neurol 6[Suppl 4]:S99-S102
7. Blinder WJ, Brin MF, Blitzer A, Schoenrock LD, Pogoda JM (2000) Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study. Otolaryngol Head Neck Surg 123:669-676
8. Silberstein S, Mathew N, Saper J, Jenkins S, for the BOTOX Migraine Clinical Research Group (2000) Botulinum toxin type A as a migraine preventive treatment. Headache 40:445-450
9. Borodic GE, Acquadro M, Johnson EA (2001) Botulinum toxin therapy for pain and inflammatory disorders: mechanisms and therapeutic effects. Expert Opin Investig Drugs 10:1531-1544
10. Stirparo G, Palazzo F, De Filippis S, Martelletti P (2003) Discrepancies between European countries and USA and Canada in the availability of triptans and in their licensed clinical properties. J Headache Pain 4:S89-S91